Activated tyrosine kinase receptors acquire ubiquitin tags. Ubiquitination governs receptor down-regulation through interaction with components of the endosomal ESCRT (endosomal sorting complexes required for transport) machinery that shepherds receptors into luminal vesicles of multivesicular bodies en route to the lysosome. We have characterized two de-ubiquitinating 
Introduction
Upon activation, many receptor tyrosine kinases become ubiquitinated following recruitment of the E3 ligase c-Cbl. In the case of EGFR [EGF (epidermal growth factor) receptor], the resultant smeared band that is seen by Western blotting was proposed to consist of a multiply mono-ubiquitinated form [1, 2] , although more recent MS analysis suggests a more complex polyubiquitin chain profile in which Lys 63 linkages predominate [3] . Note that these chains do not target proteins for proteasomal degradation, in contrast with the better characterized Lys 48 -linked chains. The first point of engagement of ubiquitinated receptors with the endosomal MVB (multivesicular body) sorting machinery is with the Hrs (hepatocyte growth factor-regulated tyrosine kinase substrate)-STAM (signal transducing adapter molecule) complex [ESCRT (endosomal sorting complexes required for transport)-0], of which both components contain UIM (ubiquitin interaction motif) domains. This complex is concentrated together with clathrin (with which Hrs interacts) in areas of the endosome covered with an unusual flat coat-structure [4] [5] [6] . Two DUBs (de-ubiquitinating enzymes), AMSH [associated molecule with the SH3 domain (Src homology 3 domain) of STAM] and UBPY (ubiquitinspecific processing protease Y), interact directly with STAM through a common binding site within its SH3 domain [7, 8] . We have characterized their activities and effects on the EGFR down-regulation pathway.
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AMSH

Enzymatic properties
AMSH belongs to the JAMM (JAB1/MPN/MOV34 metalloenzyme) family of DUBs, which are metalloproteases [9] . We used an in vitro reaction, combining purified protein together with ubiquitin chains of defined linkage, to show that AMSH has exquisite specificity for enzymatically produced, wild-type Lys 63 -over Lys 48 -linked chains [10, 11] . Moreover, co-incubation with STAM markedly stimulated this activity in a manner that requires an intact UIM domain [11] (Figure 1) . This led to a model in which AMSH activity is coupled with its interaction with STAM on endosomes, wherein STAM may capture Lys 63 -linked substrates through its UIM domain and present them to AMSH.
AMSH interactions
In addition to STAM binding, we uncovered an interaction with clathrin heavy chain through MS analysis of coimmunoprecipitating proteins. Using purified components, we confirmed that this interaction was direct and targeted against the terminal domain of clathrin. Furthermore, we showed that STAM itself can also directly interact with clathrin heavy chain [11] . A genome-wide yeast two-hybrid screen suggested that the Drosophila homologue of AMSH may interact with components of the ESCRT-III complex, Vps24 (vacuolar protein sorting 24)/CHMP3 (charged MVB protein 3) and Snf7/CHMP4 [12] , that are involved in the final stages of luminal vesicle formation. We confirmed the interaction between mammalian Vps24 and AMSH using purified components and showed that it could be stabilized by coincubation with STAM [11] . Thus both AMSH and clathrin are more deeply embedded in the MVB machinery proteininteraction network than hitherto appreciated (Figure 2) . The AMSH-STAM-Hrs complex can engage in a tripartite interaction with clathrin and AMSH may act as a bridge between ESCRT-0 and -III.
AMSH knock-down
siRNA (small interfering RNA)-mediated knock-down of AMSH enhances the rate of EGFR down-regulation in HeLa cells [10] . Although it remains to be formally shown that this is due to a loss of DUB activity, we have proposed a working model whereby AMSH acts at an early stage of the sorting process to reverse receptor ubiquitination prior to commitment to the lysosomal pathway, and thereby divert the receptor to a recycling route. In the simplest sense, AMSH can be thought of as merely opposing the E3-ligase activity of c-Cbl. 
UBPY
Enzymatic properties
UBPY shows fairly equal activity against both Lys 48 -and Lys 63 -linked ubiquitin chains [13, 14] . The activity against Lys 63 chains is lost however when chains are made using ubiquitin bearing point mutations at the other six internal lysine residues [10] .
UBPY knock-down
In our hands, UBPY knock-down using either of two targeting siRNA oligonucleotides has multiple effects on the endocytic pathway. Ubiquitin accumulates on endosomes and is drained from the nucleus and cytosol [13, 14] . EGFR and Met receptor down-regulation are both inhibited as judged by immunofluorescence (EGFR) and Western-blot analysis (EGFR and Met) [13] . Importantly, the effect on EGFR degradation could be rescued by the expression of siRNA-resistant UBPY [13] . This finding differs from that of Mizuno et al. [14] , who observed an enhanced rate of degradation when UBPY knock-down was effected by a stably transfected plasmid bearing a short hairpin-targeting sequence. We noticed that UBPY knock-down results in partial loss of Hrs (50%) and, more importantly, severely reduced (>90%) levels of STAM [13] . In the presence of a proteasome inhibitor, we detect a smeared higher molecular mass ubiquitinated form of STAM, the presence of which is entirely contingent on UBPY knock-down. Thus one function of UBPY may be to stabilize STAM by editing STAM-associated Lys 48 -linked ubiquitin chains and thereby protecting it from proteasome-mediated degradation. This function cannot overlap with AMSH owing to the differing specificities of the enzymes. The depletion of STAM may partially account for the inhibitory effect on EGFR degradation; however, this phenotype cannot be rescued by mere overexpression of STAM, suggesting that other targets remain to be discovered.
A further striking feature of knock-down cells is that they display marked differences in endosomal morphology, containing more multivesicular endosomal profiles with an altered size distribution skewed towards a greater maximal chord length. Electron microscopy also provides striking views of large numbers of MVBs 'stitched together' along extended areas of close contact by a regularly spaced repeating unit of electron-dense material with a characteristic length of 23.3 ± 3.1 nm (Figure 3 ) [13] . UBPY-depleted cells hence present with a complex pleomorphic phenotype, suggesting a key role for this DUB in endosomal dynamics.
Conclusions
AMSH and UBPY are two endosomal DUBs with differing ubiquitin chain specificities. Depletion experiments suggest that these two enzymes are both involved in the regulation of growth factor receptor trafficking, while it is currently unclear if they act in opposition to each other or rather in a co-ordinated fashion at different stages of the pathway.
